ARC1779

· Archemix Corp.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ARC1779, covering 2007-04-20 to 2010-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy [Phase 2]